中文
中文
为了病患而驱动的创新
Patient-first cell therapy innovation
 

Breaking boundaries: Current progress of anticancer NK cell-based drug development
  • 0


Highlights

NK cells are safe in allogeneic applications and therefore are ideal off-the-shelf drugs.

NK cell-based therapeutics have shown satisfying safety profiles and promising efficiency in cancer treatment.

NK cells possess a reservoir of innate immune receptors targeting various types of cancer cells.

With proper engineering, NK cells can function as the universal anti-cancer drugs that are not restricted to HLA and cancer types.

 

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer
关于天科雅
研究与发展
产品及临床
新闻与媒体
招贤纳士

Copyright © 2019 天科雅生物医药科技有限公司

粤公网安备 44011502000528号

粤ICP备20056630号 Powered by vancheer